Search

Your search keyword '"Hermann Toplak"' showing total 175 results

Search Constraints

Start Over You searched for: Author "Hermann Toplak" Remove constraint Author: "Hermann Toplak"
175 results on '"Hermann Toplak"'

Search Results

1. Treatment gaps in the implementation of LDL cholesterol control among high- and very high-risk patients in Europe between 2020 and 2021: the multinational observational SANTORINI studyResearch in context

2. Association of branched-chain amino acids with mortality-the Ludwigshafen Risk and Cardiovascular Health (LURIC) study

3. Measuring subcutaneous fat thickness using skinfold calipers vs. high-resolution B-scan ultrasonography in healthy volunteers: A pilot study

4. Evaluation of contemporary treatment of high- and very high-risk patients for the prevention of cardiovascular events in Europe – Methodology and rationale for the multinational observational SANTORINI study

5. Underestimation of resting metabolic rate using equations compared to indirect calorimetry in normal-weight subjects: Consideration of resting metabolic rate as a function of body composition

6. The ABCD of Obesity: An EASO Position Statement on a Diagnostic Term with Clinical and Scientific Implications

7. European Practical and Patient-Centred Guidelines for Adult Obesity Management in Primary Care

8. High-Protein, Low-Glycaemic Meal Replacement Improves Physical Health-Related Quality of Life in High-Risk Persons for Metabolic Syndrome—A Subanalysis of the Randomised-Controlled ACOORH Trial

9. Early and Strong Leptin Reduction Is Predictive for Long-Term Weight Loss during High-Protein, Low-Glycaemic Meal Replacement—A Subanalysis of the Randomised-Controlled ACOORH Trial

10. A High-Protein and Low-Glycemic Formula Diet Improves Blood Pressure and Other Hemodynamic Parameters in High-Risk Individuals

11. Short-Term Treatment with Alirocumab, Flow-Dependent Dilatation of the Brachial Artery and Use of Magnetic Resonance Diffusion Tensor Imaging to Evaluate Vascular Structure: An Exploratory Pilot Study

12. Effects of Alirocumab on Triglyceride Metabolism: A Fat-Tolerance Test and Nuclear Magnetic Resonance Spectroscopy Study

13. Sarcopenic Obesity: Time to Meet the Challenge

14. Practical Recommendations of the Obesity Management Task Force of the European Association for the Study of Obesity for the Post-Bariatric Surgery Medical Management

15. Obesity and Type 2 Diabetes: Two Diseases with a Need for Combined Treatment Strategies - EASO Can Lead the Way

16. A Proposal of the European Association for the Study of Obesity to Improve the ICD-11 Diagnostic Criteria for Obesity Based on the Three Dimensions Etiology, Degree of Adiposity and Health Risk

17. High-Protein, Low-Glycaemic Meal Replacement Decreases Fasting Insulin and Inflammation Markers—A 12-Month Subanalysis of the ACOORH Trial

18. Effects of a Protein-Rich, Low-Glycaemic Meal Replacement on Changes in Dietary Intake and Body Weight Following a Weight-Management Intervention—The ACOORH Trial

20. European Guidelines for Obesity Management in Adults

21. Prediabetes Conversion to Normoglycemia Is Superior Adding a Low-Carbohydrate and Energy Deficit Formula Diet to Lifestyle Intervention—A 12-Month Subanalysis of the ACOORH Trial

25. An EASO Position Statement on Multidisciplinary Obesity Management in Adults

27. Diabetes mellitus and co-morbid depression: treatment with milnacipran results in significant improvement of both diseases (results from the Austrian MDDM study group)

29. Antihyperglykämische Therapie bei Diabetes mellitus Typ 2 (Update 2023)

30. Psychische und neurokognitive Erkrankungen und Diabetes mellitus (Update 2023)

31. Nutrition for diabetic patients (Update 2023)

32. Obesity and type 2 diabetes (Update 2023)

33. Evaluation of lipoprotein(a) in the prevention and management of atherosclerotic cardiovascular disease: A survey among the Lipid Clinics Network

34. Reproductive outcomes after bariatric surgery in women

35. Evaluation of contemporary treatment of high- and very high-risk patients for the prevention of cardiovascular events in Europe – Methodology and rationale for the multinational observational SANTORINI study

36. Contemporary Treatment Gaps in the Implementation of Ldl Cholesterol Control Among High- And Very High-Risk Patients in Europe between 2020–2021 – The Multinational Santorini Study

38. Antihyperglykämische Therapie bei Diabetes mellitus Typ 2 (Update 2019)

39. Psychische Erkrankungen und Diabetes mellitus (Update 2019)

40. Ernährungsempfehlungen bei Diabetes mellitus (Update 2019)

41. Insulintherapie bei Typ 2 Diabetes mellitus (Update 2019)

42. 'Diabesity' – Adipositas und Typ-2-Diabetes (Update 2019)

43. Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

44. Meal replacement by formula diet reduces weight more than a lifestyle intervention alone in patients with overweight or obesity and accompanied cardiovascular risk factors-the ACOORH trial

45. Efficacy and tolerability of alirocumab in Austrian clinical practice – results of the non-interventional PEARL-AT study

46. Obesity and cardiovascular risk

47. Lipide: Diagnostik und Therapie bei Diabetes mellitus (Update 2019)

48. Clinical-Pathological Conference Series from the Medical University of Graz

49. A Proposal of the European Association for the Study of Obesity to Improve the ICD-11 Diagnostic Criteria for Obesity Based on the Three Dimensions Etiology, Degree of Adiposity and Health Risk

50. Was sind Barrieren der Ernährungstherapie bei mangelernährten, hospitalisierten Patienten der Inneren Medizin?

Catalog

Books, media, physical & digital resources